seed
Stage
About
Vitranu develops TERC™, a tunable extended-release capsule technology that provides sustained delivery of therapeutics for eye diseases like wet Age-Related Macular Degeneration, aiming to reduce the frequency of eye injections.
Explore Vitranu's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.